| | |
| 0247 |
10:45 AM | Overcoming Efflux Pump-Mediated Drug Resistance in Candida albicans
R.D. CANNON1, K. NIIMI1, A.R. HOLMES1, E. LAMPING1, M. KENIYA1, M. NIIMI2, and B.C. MONK1, 1University of Otago, Dunedin, New Zealand, 2National Institute of Infectious Diseases, Tokyo, Japan |
| 0248 |
11:00 AM | HIV And C. albicans Interactions In Oral Keratinocytes
A. VACHARAKSA, A.C. ASRANI, M.C. HERZBERG, and K.F. ROSS, University of Minnesota, Minneapolis, USA |
| 0249 |
11:15 AM | Critical Innate Immune Pathways in Oropharyngeal Candidiasis
B.A. HALL, O. WILDE, P. MUKHERJEE, M. GHANNOUM, T. MCCORMICK, A. WEINBERG, and A.G. HISE, Case Western Reserve University, Cleveland, OH, USA |
| 0250 |
11:30 AM | Functional Study of the Actinomyces naeslundii Fimbrial-Associated Sortase
P. CHEN, and K.P. LEUNG, US Army Dental and Trauma Research Detachment, Great Lakes, IL, USA |
| 0251 |
11:45 AM | Biological Effectiveness of Nystatin Impregnated MMA-Acrylic Resins on C. Albicans
A. NGUYEN1, A. NOBEL1, A. CAPUTO2, J. FLEISCHMANN3, and V. WU4, 1UCLA, School of Dentistry, Los Angeles, CA, USA, 2UCLA, School of Dentistry, Los Angeles, CA, USA, 3University of California - Los Angeles, USA, 4UCLA, Los Angeles, CA, USA |
| 0252 |
12:00 PM | Oral Streptococci Modulate Candida albicans Hyphal Formation and Biofilm Development
H.F. JENKINSON, A.H. NOBBS, A. D'MELLO, and L.C. DUTTON, University of Bristol, United Kingdom |
|